Olcayto Guelec and David Geuder tarapyndan Vivos Esasy Wezipesi: Oftalmologiki Hirurgiýa Ulgamy

Olcayto Guelec and David Geuder tarapyndan döredilen Vivos Esasy Wezipesi: Oftalmologiki Hirurgiýa Ulgamy dizaýny Lukmançylyk Enjamlary we Lukmançylyk Tehnikasy Dizaýny Bäsleşik Kategoriýasynda 2026 A' Design Award Altyn Baýragy baýragynyň abraýly ýeňijisidir.

AltynLukmançylyk Önümi· 2026

Vivos Esasy Wezipesi: Oftalmologiki Hirurgiýa Ulgamy

dizaýner: Olcayto Guelec and David Geuder

Müşderi: Geuder AG

Lukmançylyk Önümi Kategoriýasynda A' Design Award Altyn Baýragy Ýeňijisi

56,783

Tassyklanan Baýrak Ýeňijisi

#182492 üçin Baýrak Ýagdaýyny Barlaň

A' Design Award-da görüň Metbugat beýannamasy Baýrak nyşany

Reňkler

Dizaýn

Vivos Esasy Wezipesi: Oftalmologiki Hirurgiýa Ulgamy hakynda

Kitap Teksti: Vivos hirurgiýa iş beketini klinik maksat bilen bilelikde ösýän platforma hökmünde täzeden kesgitleýär. Üç görnüş — Core, Nova we Nova+ — ulgamy çalyşman mümkinçilikleri giňeldýär, bu bolsa oftalmologiki hirurgiýada öz görnüşinde ýeke-täk kämilleşdiriş arhitekturasydyr. Öňünden okuw geçmezden 91,7 göterim ilkinji ulanyşda kanagatlanma bilen tassyklanan ýeke-täk interfeýs, prosedura däl-de, hirurgyň töwereginde gurlan dizaýny şöhlelendirýär. Yşyklandyrylan gural birikmeleri, kämilleşdirilen materiallar we ýygnaklygyk maglumat berişi enjama bu kategoriýa mahsus görüş şowhunyndan azat, asuda we ynamly barlyk berýär.

Ykrar etme

A' Design Award Altyn Baýragy hakynda

Vivos Esasy Wezipesi: Oftalmologiki Hirurgiýa Ulgamy A' Design Award Altyn Baýragynyň ýeňijisidir; bu birinji derejeli, ajaýyp we tapawutly dizaýnlara berilýän aşa abraýly ykrarnamadyr. Altyn ýeňijileri dizaýnerleriniň alymlygyny, paýhasyny we ussatlygyny görkezýän aşa täzelikçi, uzakgörüjilikli we göz gamaşdyryjy eserlerdir. Vivos Esasy Wezipesi: Oftalmologiki Hirurgiýa Ulgamy deňi-taýy ýok gymmat berýän, köp öwülýän, ugur kesgitleýän we ýadygärlik ýaly oýlap tapyş bolmagy garaşylýar. A' Design Award Altyn Baýragyny gazanan bu dizaýn sungatyň, ylmyň, dizaýnyň we tehnologiýanyň çäklerine uly peýda berýän we ony öňe sürýän ajaýyp, hormatly taslamadyr. Vivos Esasy Wezipesi: Oftalmologiki Hirurgiýa Ulgamy güýçli isleg duýgularyny döredýär, höwesi oýarýar, döredijiligi höweslendirýär we bizi haýran edýär.

Dizaýnyň sahna arkasy

Metbugat toplumy

Dizaýner tarapyndan berlen kreditler, topar agzalary we tehniki maglumatlar.

Üýtgeşik Aýratynlyklar: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Ölçegler we Gaplama: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Bellikler: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Önümçilik Tehnologiýasy: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Dizaýn Kynçylygy: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Gözleg: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Ylham: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Taslama Dowamlylygy: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Iş Akymy: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Topar Agzalary: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Surat Awtorlary: Photography Geuder AG, 2026